Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
about
The need for greater opioid pharmacovigilance in COPDAdverse cardiac events associated with incident opioid drug use among older adults with COPD.Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep.A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) studyIntegrated respiratory and palliative care may improve outcomes in advanced lung disease.Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men.
P2860
Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prescription of opioids for br ...... tional population-based study.
@en
Prescription of opioids for br ...... tional population-based study.
@nl
type
label
Prescription of opioids for br ...... tional population-based study.
@en
Prescription of opioids for br ...... tional population-based study.
@nl
prefLabel
Prescription of opioids for br ...... tional population-based study.
@en
Prescription of opioids for br ...... tional population-based study.
@nl
P2093
P2860
P356
P1476
Prescription of opioids for br ...... tional population-based study.
@en
P2093
Eva Bernelid
Magnus Ekström
Zainab Ahmadi
P2860
P304
P356
10.2147/COPD.S112484
P407
P577
2016-10-21T00:00:00Z